Business Wire

Hero MotoSports Team Rally Starts Strong at Dakar Rally 2025

Share

Ross Branch Finishes Prologue in Second Place

Hero MotoSports Team Rally, the motorsport team of the world's largest manufacturer of motorcycles and scooters, Hero MotoCorp, has kicked off its campaign at the 47th edition of the Dakar Rally. This is the ninth consecutive appearance of Hero MotoSports at the world’s toughest race.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250104745771/en/

Hero MotoSports team at Dakar Rally 2025 (Photo: Business Wire)

Competing with a stellar line-up of three Rally GP class riders - Ross Branch, Sebastian Buhler, and Nacho Cornejo - the team started the rally on an optimistic note by finishing a short, yet challenging 29 km Prologue stage.

Defending FIM World Champion Ross Branch stormed to an impressive second-place finish, setting the tone right for the team's campaign. His teammate Sebastian Bühler crossed the finish line clocking the 9th fastest time, while Nacho Cornejo finished at the 20th position – all three of them competing in the Rally GP class.

335 vehicles made it to the start line of Dakar 2025, after successfully completing the administrative and technical scrutineering in the previous days. There are 580 competitors representing 52 nationalities at this Dakar. 134 of them are on motorbikes, which include 21 top-tier riders in the Rally GP class, and another 113 competing in Rally 2.

The weather at Bisha has been unfavourable so far, with strong winds and sandstorms making Dakar 2025 very challenging for the competitors at the bivouac, even before the official start!

Dakar 2025 which started today with a Prologue will continue for 12 stages spanning 7,700 kilometers across the vast Arabian desert. For the first time, FIM and FIA vehicles will go on separate courses across almost a staggering 45% of the overall distance. New and upgraded challenges await the competitors, including the return of the 48-hour Chrono stage - a challenging two-day effort where competitors are forced to shut off their engines at sunset, and survive on their own in secluded areas set up in the middle of the desert.

Stage 1 will be a 500 km loop exploring the desert south of Bisha. Except for sand, competitors will be racing on all sorts of surfaces including rocky and stony surfaces.

For more information:
www.heromotocorp.com | FB: /HeroMotoCorpIndia | Twitter: @HeroMotoCorp| IG: @HeroMotoCorp

Follow the team:
www.heromotosports.com | FB: /HeroMotoSports | IG: @Heromotosports

View source version on businesswire.com: https://www.businesswire.com/news/home/20250104745771/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Intends to Buy Back approximately 2.4 Million Shares in the Context of the Accelerated Bookbuild Offering by EQT, ADIA and Auba27.5.2025 17:46:00 CEST | Press release

Galderma Group AG (SWX:GALD): Ad hoc announcement pursuant to Art. 53 LR Galderma intends to repurchase approximately 2.4 million shares in the context of the accelerated bookbuild offering of Galderma shares by Sunshine SwissCo GmbH (“EQT”), Abu Dhabi Investment Authority (“ADIA”) and Auba Investment Pte. Ltd. (“Auba”) announced today The repurchased shares will be held in treasury and financed by existing liquidity at hand Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that it intends to repurchase approximately 2.4 million Galderma shares in the context of an accelerated bookbuilding offering (“ABO”) of approximately 16.7 million Galderma shares (approximately 7% of Galderma’s share capital) by EQT, ADIA and Auba. Galderma will participate in the ABO at the same price per share which will be determined in the bookbuilding. The repurchased shares will be financed by Galderma’s existing liquidity on hand and will not affect the company’s ability to de

New South Wales Minister for Industry and Trade Visits Novotech Seoul Office to Strengthen Clinical Trial Collaboration27.5.2025 17:44:00 CEST | Press release

Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong, New South Wales (NSW) Minister for Industry and Trade, to its Seoul office on May 19. The Minister’s visit highlights a deepening collaboration between South Korea and Australia in the field of clinical research and highlights the strategic importance of cross-border partnerships in advancing global drug development. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527294947/en/ Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company trusted by biotech and small- to mid-sized pharmaceutical companies to guide drug development at every phase, was honored to welcome The Hon. Anoulack Chanthivong,

LambdaTest Introduces Automation MCP Server to Revolutionize Test Failure Triaging27.5.2025 17:00:00 CEST | Press release

~New server connects AI assistants directly to test execution data, streamlining debugging and accelerating development~ LambdaTest, a unified agentic AI and cloud engineering platform, has announced the launch of its Automation MCP Server, a breakthrough solution designed to simplify and accelerate the process of triaging test failures. By enabling direct integration between AI assistants and LambdaTest’s test execution data, the Automation MCP Server empowers developers and QA engineers to investigate and resolve issues faster, without leaving their integrated development environment (IDE). The Automation MCP Server offers a seamless interface within the IDE, allowing users to access and analyze real-time test data with ease. With intelligent root cause analysis, the MCP server can quickly identify the underlying reasons for test failures and take immediate action to fix the underlying code. This results in fewer debugging cycles and faster release times. The server also enhances aut

The Six Winning Projects of the 12th Edition of the IBSA Foundation Fellowships have been Awarded and the 2025 Call is Now Open27.5.2025 16:58:00 CEST | Press release

The winners of the 2024 IBSA Foundation Fellowships Call come from two US, two Swedish, one Italian and one British universities.This year’s edition set a new record: 259 projects submitted from 45 countries.The awards ceremony was held today in Milan; during the event, the 2025 call for applications was officially opened. Research means investing in the future. This is the guiding principle behind the IBSA Foundation Fellowships programme, which for over a decade has supported talented researchers under 40 from universities and research institutions around the world. The programme awards grants to promote innovative and potentially groundbreaking projects in lesser-explored scientific fields; a constantly growing success, also confirmed by the 2024 edition, which marked a new record, with 259 applications across five scientific areas. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250522244202/en/ The Award Ceremony of the

Rigaku Completes New Building at Yamanashi Plant27.5.2025 16:00:00 CEST | Press release

Dramatic 2.7-fold increase in floor space to serve global demand Rigaku Corporation, a global solution partner in X-ray analytical technologies and a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; President and CEO: Jun Kawakami; hereinafter “Rigaku”) completed an additional manufacturing building (hereinafter “the New Building”) at Yamanashi Plant, Rigaku’s main production facility. The facility was established to serve as the center of Rigaku’s production framework, in anticipation of global business growth and expansion in product demand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250527974928/en/ Exterior view of the New Building, Yamanashi Plant Doubling of production capacity: a strategic base to support Rigaku’s growth Demand for X-ray analytical solutions has soared in recent years, both in Japan and worldwide. To respond to growing demand, Rigaku implemented this expansion with two

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye